skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Nome da Publicação: Annals Of Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines
Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines
Material Type:
Artigo 		Adicionar ao Meu Espaço

Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines

Larkin, P J ; Cherny, N I ; La Carpia, D ; Guglielmo, M ; Ostgathe, C ; Scotté, F ; Ripamonti, C I

Annals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv111-iv125 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
2
Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines
Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines
Material Type:
Artigo 		Adicionar ao Meu Espaço

Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines

Larkin, P J ; Cherny, N I ; La Carpia, D ; Guglielmo, M ; Ostgathe, C ; Scotté, F ; Ripamonti, C I

Annals of oncology, 2018-10, Vol.29 Suppl 4, p.iv111 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
3
Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy
Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy

Owen, C.N. ; Shoushtari, A.N. ; Chauhan, D. ; Palmieri, D.J. ; Lee, B. ; Rohaan, M.W. ; Mangana, J. ; Atkinson, V. ; Zaman, F. ; Young, A. ; Hoeller, C. ; Hersey, P. ; Dummer, R. ; Khattak, M.A. ; Millward, M. ; Patel, S.P. ; Haydon, A. ; Johnson, D.B. ; Lo, S. ; Blank, C.U. ; Sandhu, S. ; Carlino, M.S. ; Larkin, J.M.G. ; Menzies, A.M. ; Long, G.V.

Annals of oncology, 2020-08, Vol.31 (8), p.1075-1082 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic
Material Type:
Artigo 		Adicionar ao Meu Espaço

Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic

Sud, A. ; Jones, M.E. ; Broggio, J. ; Loveday, C. ; Torr, B. ; Garrett, A. ; Nicol, D.L. ; Jhanji, S. ; Boyce, S.A. ; Gronthoud, F. ; Ward, P. ; Handy, J.M. ; Yousaf, N. ; Larkin, J. ; Suh, Y-E. ; Scott, S. ; Pharoah, P.D.P. ; Swanton, C. ; Abbosh, C. ; Williams, M. ; Lyratzopoulos, G. ; Houlston, R. ; Turnbull, C.

Annals of oncology, 2020-08, Vol.31 (8), p.1065-1074 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy
Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy

Haanen, J. ; Ernstoff, M.S. ; Wang, Y. ; Menzies, A.M. ; Puzanov, I. ; Grivas, P. ; Larkin, J. ; Peters, S. ; Thompson, J.A. ; Obeid, M.

Annals of oncology, 2020-06, Vol.31 (6), p.724-744 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

Long, G.V. ; Flaherty, K.T. ; Stroyakovskiy, D. ; Gogas, H. ; Levchenko, E. ; de Braud, F. ; Larkin, J. ; Garbe, C. ; Jouary, T. ; Hauschild, A. ; Chiarion-Sileni, V. ; Lebbe, C. ; Mandalà, M. ; Millward, M. ; Arance, A. ; Bondarenko, I. ; Haanen, J.B.A.G. ; Hansson, J. ; Utikal, J. ; Ferraresi, V. ; Mohr, P. ; Probachai, V. ; Schadendorf, D. ; Nathan, P. ; Robert, C. ; Ribas, A. ; Davies, M.A. ; Lane, S.R. ; Legos, J.J. ; Mookerjee, B. ; Grob, J.-J.

Annals of oncology, 2017-07, Vol.28 (7), p.1631-1639 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma
DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma

Gupta, A. ; Love, S. ; Schuh, A. ; Shanyinde, M. ; Larkin, J.M. ; Plummer, R. ; Nathan, P.D. ; Danson, S. ; Ottensmeier, C.H. ; Lorigan, P. ; Collins, L. ; Wise, A. ; Asher, R. ; Lisle, R. ; Middleton, M.R.

Annals of oncology, 2014-05, Vol.25 (5), p.968-974 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma

Choueiri, T.K. ; Motzer, R.J. ; Rini, B.I. ; Haanen, J. ; Campbell, M.T. ; Venugopal, B. ; Kollmannsberger, C. ; Gravis-Mescam, G. ; Uemura, M. ; Lee, J.L. ; Grimm, M.-O. ; Gurney, H. ; Schmidinger, M. ; Larkin, J. ; Atkins, M.B. ; Pal, S.K. ; Wang, J. ; Mariani, M. ; Krishnaswami, S. ; Cislo, P. ; Chudnovsky, A. ; Fowst, C. ; Huang, B. ; di Pietro, A. ; Albiges, L.

Annals of oncology, 2020-08, Vol.31 (8), p.1030-1039 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Lethal aplastic anemia caused by dual immune checkpoint blockade in metastatic melanoma
Lethal aplastic anemia caused by dual immune checkpoint blockade in metastatic melanoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lethal aplastic anemia caused by dual immune checkpoint blockade in metastatic melanoma

Helgadottir, H. ; Kis, L. ; Ljungman, P. ; Larkin, J. ; Kefford, R. ; Ascierto, P.A. ; Hansson, J. ; Masucci, G.

Annals of oncology, 2017-07, Vol.28 (7), p.1672-1673 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Cobimetinib plus atezolizumab in BRAFV600 wild-type melanoma: primary results from the randomized phase III IMspire170 study
Cobimetinib plus atezolizumab in BRAFV600 wild-type melanoma: primary results from the randomized phase III IMspire170 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cobimetinib plus atezolizumab in BRAFV600 wild-type melanoma: primary results from the randomized phase III IMspire170 study

Gogas, H. ; Dréno, B. ; Larkin, J. ; Demidov, L. ; Stroyakovskiy, D. ; Eroglu, Z. ; Francesco Ferrucci, P. ; Pigozzo, J. ; Rutkowski, P. ; Mackiewicz, J. ; Rooney, I. ; Voulgari, A. ; Troutman, S. ; Pitcher, B. ; Guo, Y. ; Yan, Y. ; Castro, M. ; Mulla, S. ; Flaherty, K. ; Arance, A.

Annals of oncology, 2021-03, Vol.32 (3), p.384-394 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (81)

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.